How many insider trades does FilingIQ track for OBIO?

FilingIQ tracks 152 Form 4 insider transactions for OBIO (Orchestra BioMed Holdings, Inc.), covering filings from Jan 26, 2023 onwards. 7 of those were filed in the last 90 days.

Are OBIO insiders net buyers or net sellers?

Across the full Form 4 history for OBIO, 25 transactions (16%) were open-market purchases and 10 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does OBIO insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is OBIO in?

Orchestra BioMed Holdings, Inc. (OBIO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $218.80M.

OBIO insider trading

Healthcare

Orchestra BioMed Holdings, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

152

Last 90 days

Buys / sells

16% / 7%

Market cap

$218.80M

About Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.

Company website: orchestrabiomed.com

OBIO insider activity at a glance

FilingIQ has scored 152 insider transactions for OBIO since Jan 26, 2023. The most recent filing in our index is dated Apr 27, 2026.

Across the full history, 25 open-market purchases and 10 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on OBIO insider trades is 53.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live OBIO trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for OBIO?: FilingIQ tracks 152 Form 4 insider transactions for OBIO (Orchestra BioMed Holdings, Inc.), covering filings from Jan 26, 2023 onwards. 7 of those were filed in the last 90 days.
Are OBIO insiders net buyers or net sellers?: Across the full Form 4 history for OBIO, 25 transactions (16%) were open-market purchases and 10 (7%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does OBIO insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is OBIO in?: Orchestra BioMed Holdings, Inc. (OBIO) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $218.80M.

Methodology & sources

Every OBIO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.